Although DKK-1 has emerged as a key mediator in the interaction between inflammation, atherosclerosis, and CV risk, its utility as a prognostic biomarker for CVD in RA patients has not yet been thoroughly evaluated. The gene discussed is DKK1; the disease is rheumatoid arthritis.